Back
GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring.
Journal article

GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring.

  • Boehncke WH From the Department of Dermatology, Geneva University Hospital, Geneva, Switzerland.W-H. Boehncke, MD. wolf-henning.boehncke@hcuge.ch.
  • 2014-06-03
Published in:
  • The Journal of rheumatology. - 2014
CARDIOVASCULAR RISK
COMORBIDITIES
MORTALITY
MYOCARDIAL INFARCTION
PSORIASIS
SCREENING
Arthritis, Psoriatic
Cardiovascular Diseases
Humans
Psoriasis
Risk Factors
English It is now well established that psoriatic disease is associated with increased cardiovascular (CV) risk. Screening guidelines and expert recommendations for CV risk factors have been published, but these are primarily directed to specific specialists (e.g., cardiologists or diabetologists) and may not be well known in common practice. The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and other organizations are interested in adapting current comorbidity screening guidelines for use by dermatologists and rheumatologists. The resulting checklists and algorithms will need to be evaluated for practicability and performance.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/206056
Statistics
Document views: 15 File downloads: